#PCI--Prospection—the pioneer of patient-centric intelligence—today announced the availability of Prospection AI, its self-service patient-centric intelligence (PCI) platform designed to save life...
Award-winning ProGPT debuts as handy generative AI assistant for pharmaceutical brand teams to refine and explore care-and-share insights via chat experience
SYDNEY: #PCI--Prospection—the pioneer of patient-centric intelligence—today announced the availability of Prospection AI, its self-service patient-centric intelligence (PCI) platform designed to save life sciences commercial organizations time and money by unlocking insights into the complete patient care journey to achieve full market potential (care-and-share). Prospection AI is the first product offering from Prospection that embeds artificial intelligence (AI) out-of-the-box, with ProGPT—the award-winning ChatGPT-powered assistant—included in the platform to help simplify and broaden the use of real-world data in brand planning and commercial decision making.
“Prospection AI marks a new, AI-forward era for Prospection to complement the innovation journeys we see our life sciences customers on,” said Daniel West, Prospection Chief Executive Officer. “Today, we are excited to get the first-of-its-kind ProGPT assistant into the hands of commercial leaders, brand managers, and business analysts to streamline their routine analytics activities and speed their ability to explore and refine insights. In 2024, we are rapidly expanding the use of generative AI to continue to propel the value proposition of Prospection AI, including advancing ProGPT to give depth and understanding around business drivers, facilitate nuanced hypothesis testing, modernize insight into portfolio performance, and more.”
Prospection AI is purpose-built to be the PCI shared hub for brand teams, analytics teams, and commercial executives, giving each what they need, when they need it. In doing this, Prospection AI elevates commercial data fluency and insights accessibility to bring a unified understanding of care-and-share across pharmaceutical organizations.
Prospection AI builds upon a decade of healthcare analytics innovation from Prospection. Key features include:
“We hear time and time again that pharma commercial executives are looking to drive a data-driven culture across their organizations, yet analytics resources are constrained and business and/or data proficiency is limited. Prospection AI was developed to address this by broadening the reach and usability of patient-centric intelligence,” said Kirsten Mann, Prospection Chief Product Officer. “Prospection AI is the central patient data insights tool for entire cross-functional teams that support the commercialization of a drug, speeding insights for brand teams, freeing up time and effort for analytics teams, and helping leadership realize the full value of their patient data investment.”
Prospection AI is now available for purchase in Australia, Japan, and the United States. It can support more than 100 clinical indications, including those in Oncology and Immunology that require deep insight into lines of therapy and treatment regimens. Product capabilities and insights available vary by market. For more information on Prospection AI or to request a free trial and/or demo of the platform, visit https://www.prospection.com/products/.
Prospection has also published its AI Charter, which outlines the principles that guide the company’s responsible harnessing of AI in healthcare.
About Prospection
Prospection pioneers patient-centric intelligence, illuminating patient care’s impact on market share for pharmaceutical brands. Prospection's proprietary knowledge engine, the Patient-centric Intelligence Core, powers AI-forward products—including Prospection AI with the award-winning ProGPT—innovation services, and enriched data offerings to help commercial, medical, and analytics teams optimize drug performance and improve patient outcomes. For more than a decade, Prospection has worked across 20+ therapeutic areas and 100+ indications, and has been the patient-centric intelligence partner of choice for more than 100 life sciences customers. Visit www.prospection.com for more information.
Lindsey Karberg
Prospection
marketing@prospection.com
+61 2 9209 4035
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Red Hat, the world's leading provider of open source solutions, today continues to deliver customer choice in enterprise AI with the introduction of Red…
#ATS--IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today reported results from multi-site clinical experiences…
Clover, the world's smartest point-of-sale solution, under parent company, Fiserv, today announced the launch of Clover Hospitality by BentoBox at the…
Grant Thornton, one of America’s largest providers of end-to-end audit, assurance, tax and advisory services, announced today the launch of a new, proprietary…